Gregory A. Abel

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 934 citations · Full text

Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia

Stacie B. Dusetzina, Aaron N. Winn, Gregory A. Abel et al. · Journal of Clinical Oncology · 2013 · 489 citations · Full text

Race-Ethnic Disparities in the Impact of Stroke Risk Factors

Ralph L. Sacco, Bernadette Boden‐Albala, Gregory A. Abel et al. · Stroke · 2001 · 373 citations

Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies

Michael A. Liu, Clark DuMontier, Anays Murillo et al. · Blood · 2019 · 189 citations · Full text

American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

Mikkael A. Sekeres, Gordon Guyatt, Gregory A. Abel et al. · Blood Advances · 2020 · 176 citations · Full text